-
Something wrong with this record ?
Doporučení ESPGHAN stran sledování celiakie u dětí
[ESPGHAN recommendations for paediatric coeliac disease follow-up]
Nabil El-Lababidi
Language Czech Country Czech Republic
Document type Practice Guideline, Research Support, Non-U.S. Gov't
- MeSH
- Celiac Disease * diagnosis therapy MeSH
- Child MeSH
- Humans MeSH
- Tertiary Prevention MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Publication type
- Research Support, Non-U.S. Gov't MeSH
- Practice Guideline MeSH
Thanks to the ESPGHAN (European Society for Paediatric Gastroenterology, Hepatology and Nutrition) guidelines, the ideal approach to establishing the diagnosis of coeliac disease (CD) in children is clear. However, uncertainty in further follow-up of these children was present. In 2022, ESPGHAN published a position paper regarding further clinical and laboratory follow-up of children with CD. This position paper expresses its opinion regarding even controversial topics such as refractory and potential CD. Implementation of these published recommendations into clinical practice should lead to improvement in the care of paediatric CD patients.
D
í
k
y
d
o
p
o
r
u
č
e
n
ý
m
p
o
s
t
u
p
ů
m
E
S
P
G
H
A
N
(
E
u
r
o
p
e
a
n
S
o
c
i
e
t
y
f
o
r
P
a
e
d
i
a
t
r
i
c
G
a
s
t
r
o
e
n
t
e
r
o
l
o
g
y
,
H
e
p
a
t
o
l
o
g
y
a
n
d
N
u
t
r
i
t
i
o
n
-
E
v
r
o
p
s
k
á
s
p
o
l
e
č
n
o
s
t
p
r
o
d
ě
t
s
k
o
u
g
a
s
t
r
o
e
n
t
e
r
o
l
o
g
i
i
,
h
e
p
a
t
o
l
o
g
i
i
a
v
ý
ž
i
v
u
)
j
e
s
t
a
n
o
v
e
n
í
d
i
a
g
n
ó
z
y
c
e
l
i
a
k
i
e
(
C
D
)
u
d
ě
t
s
k
ý
c
h
p
a
c
i
e
n
t
ů
j
e
d
n
o
z
n
a
č
n
é
.
S
t
r
a
n
d
a
l
š
í
h
o
s
l
e
d
o
v
á
n
í
t
ě
c
h
t
o
d
ě
t
í
p
a
n
o
v
a
l
a
z
n
a
č
n
á
n
e
s
h
o
d
a
.
V
r
o
c
e
2
0
2
2
p
u
b
l
i
k
o
v
a
l
a
E
S
P
G
H
A
N
o
f
i
c
i
á
l
n
í
s
t
a
n
o
v
i
s
k
o
o
h
l
e
d
n
ě
d
a
l
š
í
h
o
s
l
e
d
o
v
á
n
í
d
ě
t
í
s
C
D
k
l
i
n
i
c
k
y
i
l
a
b
o
r
a
t
o
r
n
ě
.
T
o
t
o
s
t
a
n
o
v
i
s
k
o
s
e
v
y
j
a
d
ř
u
j
e
i
k
e
k
o
n
t
r
o
v
e
r
z
n
í
m
t
é
m
a
t
ů
m
j
a
k
o
p
o
t
e
n
c
i
á
l
n
í
a
r
e
f
r
a
k
t
e
r
n
í
c
e
l
i
a
k
i
e
.
I
m
p
l
e
m
e
n
t
a
c
e
t
ě
c
h
t
o
p
u
b
l
i
k
o
v
a
n
ý
c
h
p
o
s
t
u
p
ů
d
o
k
l
i
n
i
c
k
é
p
r
a
x
e
b
y
m
ě
l
a
v
é
s
t
k
e
z
l
e
p
š
e
n
í
p
é
č
e
o
d
ě
t
s
k
é
p
a
c
i
e
n
t
i
s
C
D
.
ESPGHAN recommendations for paediatric coeliac disease follow-up
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23005966
- 003
- CZ-PrNML
- 005
- 20230615132918.0
- 007
- ta
- 008
- 230518s2023 xr c f 000 0|cze||
- 009
- AR
- 024 7_
- $a 10.36290/ped.2023.028 $2 doi
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a cze $b eng
- 044 __
- $a xr
- 100 1_
- $a El-Lababidi, Nabil $7 xx0262600 $u Centrum dětské gastroenterologie, hepatologie a výživy, Klinika pediatrie a dědičných poruch metabolismu VFN a 1. LF UK, Praha
- 245 10
- $a Doporučení ESPGHAN stran sledování celiakie u dětí / $c Nabil El-Lababidi
- 246 31
- $a ESPGHAN recommendations for paediatric coeliac disease follow-up
- 520 __
- $a Díky doporučeným postupům ESPGHAN (European Society for Paediatric Gastroenterology, Hepatology and Nutrition - Evropská společnost pro dětskou gastroenterologii, hepatologii a výživu) je stanovení diagnózy celiakie (CD) u dětských pacientů jednoznačné. Stran dalšího sledování těchto dětí panovala značná neshoda. V roce 2022 publikovala ESPGHAN oficiální stanovisko ohledně dalšího sledování dětí s CD klinicky i laboratorně. Toto stanovisko se vyjadřuje i ke kontroverzním tématům jako potenciální a refrakterní celiakie. Implementace těchto publikovaných postupů do klinické praxe by měla vést ke zlepšení péče o dětské pacienti s CD.
- 520 9_
- $a Thanks to the ESPGHAN (European Society for Paediatric Gastroenterology, Hepatology and Nutrition) guidelines, the ideal approach to establishing the diagnosis of coeliac disease (CD) in children is clear. However, uncertainty in further follow-up of these children was present. In 2022, ESPGHAN published a position paper regarding further clinical and laboratory follow-up of children with CD. This position paper expresses its opinion regarding even controversial topics such as refractory and potential CD. Implementation of these published recommendations into clinical practice should lead to improvement in the care of paediatric CD patients.
- 650 17
- $a celiakie $x diagnóza $x terapie $7 D002446 $2 czmesh
- 650 _7
- $a terciární prevence $7 D055512 $2 czmesh
- 650 _7
- $a dítě $7 D002648 $2 czmesh
- 650 _7
- $a lidé $7 D006801 $2 czmesh
- 655 _7
- $a směrnice pro lékařskou praxi $7 D017065 $2 czmesh
- 655 _7
- $a práce podpořená grantem $7 D013485 $2 czmesh
- 773 0_
- $t Pediatrie pro praxi $x 1213-0494 $g Roč. 24, č. 2 (2023), s. 95-97 $w MED00011583
- 856 41
- $u https://www.pediatriepropraxi.cz/artkey/ped-202302-0003_doporuceni_espghan_stran_sledovani_celiakie_u_deti.php $y plný text volně přístupný
- 910 __
- $a ABA008 $b B 2226 $c 729 $y p $z 0
- 990 __
- $a 20230504 $b ABA008
- 991 __
- $a 20230615132913 $b ABA008
- 999 __
- $a ok $b bmc $g 1938703 $s 1192184
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2023 $b 24 $c 2 $d 95-97 $e 20230405 $i 1213-0494 $m Pediatrie pro praxi $x MED00011583
- LZP __
- $c NLK182 $d 20230615 $b NLK111 $a Actavia-MED00011583-20230504
